Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature
Sertoli-Leydig Cell Tumors (SLCTs) make up <1% of all ovarian tumors and are benign or malignant, androgen-secreting tumors. Rhabdomyosarcoma (RMS) is a heterogeneous group of malignant tumors that resemble developing skeletal muscle. There have been case reports of patients with concurrent SLCT...
Saved in:
Main Authors: | Trisha Plastini, Arthur Staddon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/4587296 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sertoli-Leydig Cell Tumour and DICER1 Mutation: A Case Report and Review of the Literature
by: B. Wormald, et al.
Published: (2018-01-01) -
Frozen Section Diagnostic Pitfalls of Sertoli-Leydig Cell Tumor with Heterologous Elements
by: Ashley Burris, et al.
Published: (2018-01-01) -
Giant Sertoli-Leydig cell tumor of ovary in a 12-year-old girl
by: Siwei Zhong, et al.
Published: (2025-02-01) -
Two Years of Gynecomastia Caused by Leydig Cell Tumor
by: Philip Zeuschner, et al.
Published: (2018-01-01) -
Synchronous Leydig Cell Tumor and Seminoma in the Ipsilateral Testis
by: Ifeyinwa E. Obiorah, et al.
Published: (2018-01-01)